International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2 , Pages 316-327 , 1 June 2002

Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer

Presented at the 42nd ASTRO meeting in Boston, MA, November 2000.

  • Alvaro A Martinez, M.D. (F.A.C.R.)

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    • Corresponding Author InformationReprint requests to: Alvaro Martinez, M.D., F.A.C.R., Department of Radiation Oncology, William Beaumont Hospital, 3601 W. Thirteen Mile Rd., Royal Oak, MI 48073 USA. Tel: (248) 551-7058; Fax: (248) 551-7845
    • ,
  • Gary Gustafson, M.D.

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • José Gonzalez, M.D.

      Affiliations

    • Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Elwood Armour, Ph.D.

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Chris Mitchell, R.N. (B.S.N.)

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Gregory Edmundson, M.S.

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • William Spencer, M.D.

      Affiliations

    • Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Jannifer Stromberg, M.D.

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Raywin Huang, Ph.D.

      Affiliations

    • Department of Biostatistics Research Institute, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Frank Vicini, M.D.

      Affiliations

    • Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA

Received 16 October 2001 ,Revised 26 December 2001 ,Accepted 16 January 2002.

References 

  1. Bagshaw MA, Cox RS, Ray GR. Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr. 1988;7:47–60
  2. Perez CA, Pilepich MV, Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1986;12:523–531
  3. Hanks GE, Diamond JJ, Krall JM, et al.  A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys. 1987;13:499–505
  4. Zagars GK, von Eschenbach AC, Johnson DE, et al.  Stage C adenocarcinoma of the prostate (An analysis of 551 patients treated with external beam irradiation). Cancer. 1987;60:1489–1499
  5. Leach GE, Cooper JF, Kagan AR, et al.  Radiotherapy for prostatic carcinoma (Post-irradiation prostatic biopsy and recurrence patterns with long-term followup). J Urol. 1982;128:505–509
  6. Cox JD, Kline RW. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma (Stage III, predict long-term survival?). Int J Radiat Oncol Biol Phys. 1983;9:299–303
  7. Fuks Z, Leibel SD, Wallner KE, et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate (Long term results in patients treated with I-125 implantation). Int J Radiat Oncol Biol Phys. 1991;21:537–547
  8. Perez CA. Prostate. In:  Perez CA,  Brady LW editor. Principles and practice of radiation oncology. 3rd ed.. Philadelphia: Lippincott-Raven; 1997;p. 1583–1694
  9. Pilepich MV, Krall JM, Al-Sarraf M, et al.  Androgen deprivation with radiation therapy alone for locally advanced prostatic carcinoma (A randomized comparative trial of the Radiation Therapy Oncology Group). Urology. 1995;45:616–623
  10. Bolla M, Gonzalez D, Warde P, et al.  Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 1997;337:295–300
  11. Laverdiere J, Gomez JL, Cusan L, et al.  Beneficial effect of combination hormonal therapy administered prior and following external beam irradiation in localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:247–252
  12. Shipley WU, Verhey LJ, Munzenrider JE, et al.  Advanced prostate cancer (The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone). Int J Radiat Oncol Biol Phys. 1995;32:3–12
  13. Forman JD, Porter AT. The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate. Semin Urol Oncol. 1997;15:239–243
  14. Ragde H, Elgamal AA, Snow PB, et al.  Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 1998;83:989–1001
  15. Dattoli M, Wallner K, Sorace R, et al.  Pd 103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys. 1996;35:875–879
  16. Zelefsky MJ, Leibel SA, Gaudin PB, et al.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41:491–500
  17. Hanks GE, Hanlon AL, Pinover WH, et al.  Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 1999;5:152–158
  18. Martinez A, Gonzalez J, Stromberg J, et al.  Conformal prostate brachytherapy (Initial experience of a phase I/II clinical trial). Int J Radiat Oncol Biol Phys. 1995;33:1019–1027
  19. Stromberg J, Martinez A, Gonzalez J, et al.  Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer (Treatment description and preliminary results of a phase I/II clinical trial). Int J Radiat Oncol Biol Phys. 1995;33:161–171
  20. Beard CJ, Kijewski P, Bussiere M, et al.  Analysis of prostate and seminal vesicle motion (Implications for treatment planning). Int J Radiat Oncol Biol Phys. 1996;34:451–458
  21. Melian E, Mageras GS, Fuks Z, et al.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 1997;38:73–81
  22. Yan D, Ziaja E, Jaffray D, et al.  The use of adaptive radiation therapy to reduce setup error (A prospective clinical study). Int J Radiat Oncol Biol Phys. 1998;41:715–720
  23. Jaffray DA, Yan D, Wong JW. Managing geometric uncertainty in conformal intensity-modulated radiation therapy. Semin Radiat Oncol. 1999;9:4–19
  24. Yan D, Vicini F, Wong J, et al.  Adaptive radiation therapy. Phys Med Biol. 1997;42:123–132
  25. Yan D, Wong J, Vicini F, et al.  Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys. 1997;38:197–206
  26. Martinez AA, Yan D, Lockman D, et al.  Improvement in dose escalation using the process of adaptive radiotherapy combined with 3D-conformal or intensity modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys. 2001;50:1226–1234
  27. Edmundson GK. Geometry based optimization for stepping source implants. In:  Martinez AA,  Orton CG,  Mould RF editor. Brachytherapy HDR and LDR. Columbia, MD: Nucletron; 1990;p. 184–192
  28. Edmundson GK, Rizzo N, Teahan M, et al.  Concurrent treatment planning for outpatient high dose rate prostate template implants. Int J Radiat Oncol Biol Phys. 1993;27:1215–1223
  29. Edmundson GK, Yan D, Martinez A. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;33:1257–1264
  30. Gustafson G, Edmundson GK, Vicini F, et al.  Overcoming internal prostate motion and set-up inaccuracies with conformal interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 1995;32(Suppl.):199
  31. Martinez AA, Kestin LL, Stromberg JS, et al.  Interim report of image-guided conformal high-dose rate brachytherapy for patients with unfavorable prostate cancer (The William Beaumont Phase II dose-escalating trial). Int J Radiat Oncol Biol Phys. 2000;47:343–352
  32. Stromberg JS, Martinez AA, Horwitz EM, et al.  Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer (Superior prostate-specific antigen response compared with external beam treatment). Cancer J Sci Am. 1997;3:346–352
  33. Kestin LL, Martinez AA, Stromberg JS, et al.  Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol. 2000;18:2869–2880
  34. Pataki I, Martinez A, Gonzalez J; et al. Lack of benefit for neoadjuvant androgen deprivation for locally advanced prostate cancer treated with external beam radiotherapy and conformal high dose rate brachytherapy. Submitted for publication.
  35. Fowler JF. Review (Total doses in fractionated radiotherapy—Implications of new radiobiological data). Int J Radiat Oncol Biol Phys. 1984;46:103–120
  36. Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8:1981–1997
  37. Brenner DJ, Hall EJ. Fractionation and protraction of radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:1095–1101
  38. Duchesne GM, Petes LJ. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;44:747–748
  39. Brenner DJ, Martinez AA, Edmundson GK, et al.  Direct evidence that prostate tumors show high sensitivity to fraction (low α/β ratio), comparable to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 2002;52:6–13
  40. Goldstein NS, Kestin L, Martinez AA. Prostate adenocarcinoma volume and radiation dose are the primary factors in the dose-response relationship of unfavorable prostate adenocarcinoma. Am J Clin Pathol. In press.
  41. Consensus statement. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  42. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  43. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1996;50:163–170
  44. Cox DR. Regression m models and life-tables. J R Stat Soc B. 1972;34:187–220
  45. Borghede G, Hedelin H, Holmany S, et al.  Combined treatment with temporary short term high dose rate Ir-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol. 1997;44:237–244
  46. Dinges S, Deger S, Koswig S, et al.  High dose rate interstitial with external beam irradiation for localized prostate cancer—Results of a prospective trial. Radiother Oncol. 1998;48:197–202
  47. Kovacs G, Wirth B, Berterman H, et al.  Prostate preservation by combined external beam and HDR brachytherapy at node negative prostate cancer patients (An intermediate analysis after 10 years experience). Int J Radiat Oncol Biol Phys. 1996;36:198
  48. Mate TP, Gottesman JE, Hatton J, et al.  High dose-rate afterloading iridium-192 prostate brachytherapy (Feasibility report). Int J Radiat Oncol Biol Phys. 1998;41:525–533
  49. Martinez AA, Pataki I, Edmundson G, et al.  Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer (A feasibility report). Int J Radiat Oncol Biol Phys. 2001;49:61–69

PII: S0360-3016(02)02733-5

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2 , Pages 316-327 , 1 June 2002

Article Tools

* Image Usage & Resolution